CONFERENCE AGENDA -- THURSDAY, MAY 11


WEDNESDAY MAY 10          THURSDAY MAY 11

TIME PROGRAM LOCATION
7:00AM-12:00PM CHECK-IN AND REGISTRATION REGISTRATION DESK
7:30AM-8:30AM CEO BREAKFAST (INVITATION ONLY)
Sponsored by
CITY ROOM
7:30AM-8:30AM CSO BREAKFAST (INVITATION ONLY)
Sponsored by
     
CIRCLE ROOM
9:00AM-10:00AM

PLENARY SESSION
INNOVATION AND ITS ABILITY TO TRANSFORM HEALTHCARE
New York is at the leading edge of a seismic shift in healthcare, and we must contemplate and adopt policies that support innovation.  We cannot base long-term policy initiatives on one-year snapshots of upfront drug costs and expect to solve any problems.

Whether it's exploring new models for more efficient R&D, piloting innovative pricing models, or working directly with patients to define desired outcomes and endpoints, our shared mission is to rid the world of disease.

This panel discussion will focus on how we must shift our perspective, and the incentives in the healthcare system itself, to a longer horizon that can capture complete measures of cost, value and patient outcomes.  

Panelists:

COLUMBUS ROOM
10:00AM-3:00PM 1x1 PARTNERING PARTNERING ZONE
10:00AM-11:15AM CONCURRENT SESSIONS  
 
In this session, panelists will explore the role incubators play as innovation ecosystems in helping early-stage life sciences companies advance promising science into products for patients and consumers. As a result of recent government and industry commitments to build the life sciences industry in New York, we can expect to see an explosion in the number of entrepreneurs and innovators launching companies in the region. Such innovation ecosystems are a vital piece of a thriving biotech and life sciences community because they provide valuable support for young companies. Incubator resident companies benefit from resources ranging from lab equipment and business facilities to opportunities for funding and access to mentors. Panelists representing industry, the startup community, and regional life sciences organizations will share their perspective on the advantages to leveraging incubators in the New York City region.
TOWER EAST
 
The 21st Century Cures Act was a major bipartisan legislation that requires significant rulemaking and guidance activity by FDA in 2017. However, the Trump Administration policies for reduced regulatory burden and FDA priorities do not align entirely with the statutory directives. This session will dive deep into the progress made in implementing 21st Century Cures requirements and discuss the intersection with Trump’s FDA priorities.
TOWER WEST
 
The panel will discuss different ways/models that IP is being used to promote technology, business and progress in the life sciences.
HUDSON ROOM
 
Early stage life science companies have challenges in marrying the business and science and cost effectively moving a product to value inflection in a timely manner. This session will examine a number of innovative models for taking new products further along the value chain with panelists who are current leaders of the organizations.
CITY ROOM
11:30AM-12:45PM CONCURRENT SESSIONS  
  TOWER EAST
 
Panel will discuss how a potential licensee should prepare and approach their meeting with a sophisticated licensor. 
  • Joseph Saphia, partner, haug Partners LLP
  •   Peter Cicala, VP Intellectual Property, Celgene
  •   Kevin McGough, Sr. Director, IP Legal, Shire Pharmaceuticals 
  •   Glenn Sblendorio, President and CEO, Opthotech
  •   David Herman, Partner, Haug Partners LLP
TOWER WEST
 
The discussion will be centered on: * The use of genetic data in consumer health * New ways in which the use of genetic data is revolutionizing clinical research. * The collection of genetic data through wearable biosensors and mobile applications. * The impact of the 21st Century Cures Act on the use and protection of genetic data. * The balance between harnessing the promise of genetic data and safeguarding privacy.
HUDSON ROOM
 
The growing population of CRISPR patent owners holding exclusive licensing rights on >1000 patent families worldwide brings the topic of patent pooling in biotech to the foreground. A patent pool provides direct non-exclusive licensing access to a collection of essential patents, managed by an independent thrid party. Patent pools revolutionized digital video development in the 1990s, and could have a calling in the development of CRISPR technology and other tech tools.
CITY ROOM
  CIRCLE ROOM
1:00PM-2:15PM LUNCHEON PROGRAM
     
PITCHFEST AWARDS
     STATE OF THE INDUSTRY REPORT
 
2:30PM-3:45PM CONCURRENT SESSIONS  
 
The Michael J Fox Foundation (MJFF) has developed a consortium model for undertaking pre-competitive collaborative research involving partners from patient foundations, Pharma, academia and CROs. Charles River is providing the CRO support for three such consortia. This session will showcase three ongoing projects, highlighting the project goals, working relationships and current status. Representatives of MJFF and Charles River will speak about the MJFF model, the benefits of a collaborative approach between public and private bodies and learnings that can be applied to similar research initiatives. The following three projects will be presented: • Alpha-synuclein PET ligand • Alpha-synuclein toxicity screen • Animal models for LRRK2 projects
TOWER WEST
 
Finding the best talent for your company is an ongoing challenge for many. Learn about how to effectively partner with area universities to identify top graduate student/alumni talent.
HUDSON ROOM
 
  • Ross Cagan, PhD,  Associate Dean, Mount Sinai School of Biomedical Sciences; Professor of Cell, Development & Regenerative Biology and Oncological Sciences; Professor of Opthalmology, Mount Sinai School of Medicine
  • Neville Sanjana, PhD, Assistant Professor of Biology, Neuroscience and Physiology, NY Genome Center and New York University
  • Andrew Marshall, PhD, Chief Editor, Nature BiotechnologY
  • Steve Festin, PhD, Senior Strategic Technical Product Manager, Charles River Laboratories
  • Jacob Sherkow, JD, Associate Professor, New York Law School; Affiliated Faculty, Innovation Center for Law and Technology, New York Law School and Innovation Center for Law and Technology
  • Prem Premsrirut, MD/PhD, President/CEO, Mirimus, Inc.
CITY ROOM
4:00PM-6:00PM CLOSING RECEPTION
Sponsored by
     
HUDSON HOTEL TERRACE BAR

Schedule and agenda are subject to change